(Q34228220)

31 July 2017

title

Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases (English)

1 reference

31 July 2017

Xavier Franck

9

0 references

Antonieta Rojas de Arias

object named as

Antonieta Rojas de Arias

7

0 references

author name string

Hector Nakayama

1

1 reference

31 July 2017

Philippe M Loiseau

2

1 reference

31 July 2017

Christian Bories

3

1 reference

31 July 2017

Susana Torres de Ortiz

4

1 reference

31 July 2017

Alicia Schinini

5

1 reference

31 July 2017

Elsa Serna

6

1 reference

31 July 2017

Mohamed A Fakhfakh

8

1 reference

31 July 2017

Bruno Figadère

10

1 reference

31 July 2017

Reynald Hocquemiller

11

1 reference

31 July 2017

Alain Fournet

12

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

49

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

4950-4956

1 reference

Biological evaluation of substituted quinolines

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Substituted quinolines induce inhibition of proliferation of HTLV-1 infected cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Oral miltefosine for Indian visceral leishmaniasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Sitamaquine (GlaxoSmithKline/Walter Reed Army Institute).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Identification of genes induced by a macrophage activator, S-28463, using gene expression array analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Presence of a Na(+)/H(+) exchanger in acidocalcisomes of Leishmania donovani and their alkalization by anti-leishmanial drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

The effect of some 2-substituted quinolines isolated from Galipea longiflora on Plasmodium vinckei petteri infected mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Ca2+ transport by digitonin-permeabilized Leishmania donovani. Effects of Ca2+, pentamidine and WR-6026 on mitochondrial membrane potential in situ

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Availability of miltefosine for the treatment of kala-azar in India.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Decrease of intestinal P-glycoprotein activity by 2n-propylquinoline, a new oral treatment for visceral leishmaniasis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Determination of the human cytochrome P450s involved in the metabolism of 2n-propylquinoline

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315925

Determination of 2-n-propylquinoline in mouse plasma and liver by high-performance liquid chromatography

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16304157

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fine-structural Alterations inLeishmania tropicawithin Human Macrophages Exposed to Antileishmanial Drugs in Vitro1

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16304157

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.49.12.4950-4956.2005

1 reference

31 July 2017

1 reference

31 July 2017

1 reference